Could Seres Therapeutics Inc (MCRB) stock price achieve new all-time highs if its expected earnings and revenue increase?
In yesterday’s Wall Street session, Seres Therapeutics Inc (NASDAQ:MCRB) shares traded at $0.69, down -2.82% from the previous session. MCRB stock price is now -28.20% away from the 50-day moving average and -67.51% away from the 200-day moving average. The market capitalization of the company currently stands at $104.11M. On April 21, 2023, JP Morgan […]
How Do Seres Therapeutics Inc (NASDAQ:MCRB)’s Fundamentals Affect Performance
The price of Seres Therapeutics Inc (NASDAQ:MCRB) shares last traded on Wall Street rose 4.07% to $0.76. MCRB stock price is now -24.02% away from the 50-day moving average and -65.93% away from the 200-day moving average. The market capitalization of the company currently stands at $114.03M. On April 21, 2023, JP Morgan recently initiated […]
Seres Therapeutics Inc (MCRB) Holding Strong: What’s pushing it?
The price of Seres Therapeutics Inc (NASDAQ:MCRB) shares last traded on Wall Street rose 9.00% to $1.05. Based on available information, 7 analysts follow Seres Therapeutics Inc (NASDAQ:MCRB). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a low of […]
Before You Invest In Seres Therapeutics Inc (NASDAQ:MCRB), Consider This Metric
Stocks of Seres Therapeutics Inc (NASDAQ:MCRB) traded higher last session on Wall Street, up 7.72% to $1.04. According to the data, Seres Therapeutics Inc (NASDAQ:MCRB) has 7 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and […]
Does Seres Therapeutics Inc (NASDAQ:MCRB) warrant a purchase right now? What to Consider Before Making a Decision
The stock of Seres Therapeutics Inc (NASDAQ:MCRB) last traded at $1.22, up 7.02% from the previous session. Data from the available sources indicates that Seres Therapeutics Inc (NASDAQ:MCRB) is covered by 7 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
The shares of Seres Therapeutics Inc (MCRB) have recorded the market capitalization of 119.54M
The stock of Seres Therapeutics Inc (NASDAQ:MCRB) last traded at $0.93, down -35.25% from the previous session. Data from the available sources indicates that Seres Therapeutics Inc (NASDAQ:MCRB) is covered by 7 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
How Do Seres Therapeutics Inc. (NASDAQ:MCRB)’s Fundamentals Affect Performance
The price of Seres Therapeutics Inc. (NASDAQ:MCRB) shares last traded on Wall Street rose 1.45% to $3.50. Based on available information, 7 analysts follow Seres Therapeutics Inc. (NASDAQ:MCRB). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a low of […]
How should investors evaluate Seres Therapeutics Inc. (NASDAQ:MCRB)?
In yesterday’s Wall Street session, Seres Therapeutics Inc. (NASDAQ:MCRB) shares traded at $4.69, up 6.11% from the previous session. As of this writing, 7 analysts cover Seres Therapeutics Inc. (NASDAQ:MCRB). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a […]
Seres Therapeutics Inc. (NASDAQ:MCRB) Risks You Should Know Before Investing
The price of Seres Therapeutics Inc. (NASDAQ:MCRB) shares last traded on Wall Street fell -3.70% to $4.69. As we calculate the median target price by taking the range between a high of $15.00 and a low of $4.00, we find $11.00. Given the previous closing price of $4.87, this indicates a potential upside of 125.87 […]
